Respiratory Physiotherapy in Mechanical Ventilation

December 13, 2020 updated by: Canan Gursoy, Muğla Sıtkı Koçman University

the Effect of Respiratory Physiotherapy to Weaning in Invasive Mechanical Ventilation

This study aimed to evaluate the effect of respiratory physiotherapy that is breathing exercise during weaning on ventilated patients in ICU.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Respiratory physiotherapy is a treatment approach to increase ventilation and function in patients with acute and chronic problems and to reduce respiratory work and dyspnea.Airway cleaning techniques, lung volume-enhancing approaches, thoracic mobilization, positioning, breathing exercises and inhalation therapy are among the strategies used.

In patients with invasive MV support, respiratory physiotherapy is the position, tracheal cleaning and inhalation therapy when necessary. But breathing exercises are not indicated in the acute phase. In the process of weaning, inspiratory muscle training and breathing exercises can be used.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mugla, Turkey, 48000
        • Mugla Sıtkı Kocman University Reasearch and Treaninig Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • weaning period of patients in invasive mechanical ventilation
  • patients in stable hemodynamic parameters

Exclusion Criteria:

  • under 18 years old
  • pregnant
  • non-cooperative

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SPT
diaphragmatic breathing exercise that used during weaning is the respiratory physiotherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
weaning success
Time Frame: 1-7 days
effect of respiratory physiotherapy as diaphragmatic exercise of weaning
1-7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compliance
Time Frame: 1-7 days
effect of diaphragmatic exercise on compliance, diaphragmatic movement
1-7 days
diaphragmatic movement
Time Frame: 1-7 days
effect of diaphragmatic exercise on diaphragmatic movement
1-7 days
arterial blood gas
Time Frame: 1-7 days
effect of diaphragmatic exercise on diaphragmatic movement
1-7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Canan Gürsoy, Muğla Sıtkı Koçaman University, Training And Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2018

Primary Completion (Actual)

March 18, 2019

Study Completion (Actual)

August 1, 2019

Study Registration Dates

First Submitted

August 18, 2019

First Submitted That Met QC Criteria

December 13, 2020

First Posted (Actual)

December 17, 2020

Study Record Updates

Last Update Posted (Actual)

December 17, 2020

Last Update Submitted That Met QC Criteria

December 13, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • SFT-CNN

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on breath exercises

3
Subscribe